SENSEI BIOTHERAPEUTICS
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. The company developing novel biologics therapies targeting key components of the immune system for the treatment of cancers of unmet need. They are also focused on the discovery, development, and delivery of medicines that alter the treatment landscape and contributing value to patients and society. Sensei Biotherapeutics using its proprietary drug discovery plat... form to study and understand the tumor microenvironment and identify a new class of cancer immunotherapies that act through new biology and differentiated mechanisms. It brings together scientific leaders in biology, immunology, and oncology along with a highly experienced management team and scientific advisors. The company's platform, ImmunoPhage enables the generation of immune-activating agents that fully engage activation of both the innate and adaptive immune systems. Sensei Biotherapeutics is headquartered in Gaithersburg, Maryland with an office in Boston, MA, USA.
SENSEI BIOTHERAPEUTICS
Industry:
Biotechnology Health Diagnostics Life Science Medical Therapeutics
Founded:
1999-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.senseibio.com
Total Employee:
11+
Status:
Active
Contact:
+1.240.243.8000
Total Funding:
58.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins
Similar Organizations
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Pauline Callinan Vice President Of Business Development @ Sensei Biotherapeutics
Vice President Of Business Development
Edward van der Horst Vice President pf Preclinical Development @ Sensei Biotherapeutics
Vice President pf Preclinical Development
Robert Pierce Chief Scientific Officer @ Sensei Biotherapeutics
Chief Scientific Officer
Ildiko Csiki Chief Medical Officer @ Sensei Biotherapeutics
Chief Medical Officer
John K. Celebi President and CEO @ Sensei Biotherapeutics
President and CEO
Jean Campbell Vice President of Biologics Discovery @ Sensei Biotherapeutics
Vice President of Biologics Discovery
Alice Drumheller Vice President of Clinical Operations @ Sensei Biotherapeutics
Vice President of Clinical Operations
Steven A. Fuller Chief Biopharmaceuticals Development Officer @ Sensei Biotherapeutics
Chief Biopharmaceuticals Development Officer
Patrick Gallagher Chief Business Officer @ Sensei Biotherapeutics
Chief Business Officer
2022-06-01
Hossein Ghanbari Co-Founder @ Sensei Biotherapeutics
Co-Founder
Founder
Stock Details
Investors List
Korify Capital AG
Korify Capital AG investment in Series B - Sensei Biotherapeutics
infinitas capital group
infinitas capital group investment in Series B - Sensei Biotherapeutics
Pura Vida Investments
Pura Vida Investments investment in Series B - Sensei Biotherapeutics
Apeiron Investment Group
Apeiron Investment Group investment in Series B - Sensei Biotherapeutics
Catalio Capital Management
Catalio Capital Management investment in Series B - Sensei Biotherapeutics
Future Ventures
Future Ventures investment in Series B - Sensei Biotherapeutics
Cambrian Biopharma
Cambrian Biopharma investment in Series B - Sensei Biotherapeutics
Moore Strategic Ventures
Moore Strategic Ventures investment in Series B - Sensei Biotherapeutics
Presight Capital
Presight Capital investment in Series B - Sensei Biotherapeutics
Future Ventures
Future Ventures investment in Series A - Sensei Biotherapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-01 | Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer |
Official Site Inspections
http://www.senseibio.com Semrush global rank: 4.23 M Semrush visits lastest month: 2.78 K
- Host name: 172.67.135.94
- IP address: 172.67.135.94
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sensei Biotherapeutics"
Sensei Bio » We Learn Cancer's Design
Sensei Biotherapeutics follows the immune system’s teachings to discover new treatments that inspire the body to fight cancer.See details»
Sensei Biotherapeutics - Crunchbase Company Profile & Funding
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. The company developing novel biologics therapies …See details»
Sensei Bio - Overview, News & Similar companies | ZoomInfo.com
Mar 22, 2024 Sensei Bio contact info: Phone number: (240) 243-8000 Website: www.senseibio.com What does Sensei Bio do? Sensei Biotherapeutics is a biopharmaceutical …See details»
Sensei Bio - Company Profile & Staff Directory - ContactOut
Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system …See details»
Sensei Bio - LinkedIn
Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer.See details»
Life at Sensei » Sensei Bio
Our team is comprised of lifelong learners striving for insight at the intersection of immunology, oncology and biology. We thrive when we learn and believe nature is our best teacher.See details»
Sensei Biotherapeutics - BIO International Convention | BIO
Jun 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Sensei …See details»
News Release Details - investors.senseibio.com
Dec 16, 2021 HQ: 1405 Research Blvd, Suite 125, Rockville, MD 20850. MA: 22 Boston Wharf Rd, 7th Floor, Boston, MA 02210See details»
News Release Details - investors.senseibio.com
Nov 14, 2024 For more information, please visit www.senseibio.com, and follow the company on X @SenseiBio and LinkedIn. Condensed Statements of Operations (Unaudited, in thousands …See details»
Sensei Biotherapeutics Provides Update on Strategic Priorities
Dec 8, 2022 For more information, please visit www.senseibio.com, and follow the company on Twitter @SenseiBio and LinkedIn. Cautionary Note Regarding Forward-Looking Statements …See details»
Finance & Science: Two Sides of the Same Coin » Sensei Bio
HQ: 1405 Research Blvd, Suite 125, Rockville, MD 20850. MA: 22 Boston Wharf Rd, 7th Floor, Boston, MA 02210See details»
Sensei Biotherapeutics Provides Corporate Update and Highlights …
Jan 4, 2024 mbiega@senseibio.com. Media Contact: Joyce Allaire LifeSci Advisors Jallaire@lifesciadvisors.com Markets Insider and Business Insider Editorial Teams were not …See details»
News Release Details - investors.senseibio.com
Mar 28, 2023 Sensei Biotherapeutics (Nasdaq: SNSE) is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients.See details»
Sensei Biotherapeutics Named a Winner of Comparably’s Best
Dec 16, 2021 For more information, please visit www.senseibio.com, and follow the company on Twitter @SenseiBio and LinkedIn. Investor Contact: Erin Colgan SVP, Finance and …See details»
Sensei Biotherapeutics Announces Addition to the Nasdaq …
BOSTON, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next …See details»
News Release Details - Sensei Biotherapeutics, Inc
For more information, please visit www.senseibio.com, and follow the company on Twitter @SenseiBio and LinkedIn. Cautionary Note Regarding Forward-Looking Statements Any …See details»
A Vision for VISTA - Sensei Bio
Developing a new cancer immunotherapy is rarely a linear or simple path, but the reward of sticking with it is unmatched. I recently sat down with Sensei’s CSO, Edward van der Horst, to …See details»
Approach - Sensei Bio
Taking our lessons from the immune system, we develop highly selective therapeutics. Expanding the range of immunotherapy options has been challenging for a number of reasons, including …See details»
Pipeline - Sensei Bio
Sensei is developing a pipeline of investigational medicines that have potential to alter the relationship between host immune cells and cancer so that the immune system recognizes …See details»